REFERENCES
G. F. Koob, C. Lebrun, R. M. Bluthe, R. Dantzer, and M. Le Moal, Role of neuropeptides in learning versus performance: focus on vasopressin. Brain Res. Bull. 23:359-364 (1989).
E. Fliers, G. J. De Vries, and D. F. Swaab. Changes with aging in the vasopressin and oxytocin innervation of the rat brain. Brain Res. 348:1-8 (1985).
T. Araki, H. Kato, T. Inoue, and K. Kogure. Regional impairment of protein synthesis following brief cerebral ischemia in the gerbil. Acta Neuropathol. 79:501-505 (1990).
A. S. Fleming, U. S. Cheung, and M. Barry. Cycloheximide blocks the retention of maternal experience in postpartum rats. Behav. Neural Biol. 53:64-73 (1990).
S. Shibata, T. Hamada, K. Tominaga, and S. Watanabe. An in vitro circadian rhythm of protein synthesis in the rat suprachiasmatic nucleus under tissue cultured condition. Brain Res. 584:251-256 (1992).
S. Feig and P. Lipton. Pairing the cholinergic agonist carbachol with patterned Schaffer collateral stimulation initiates protein synthesis in hippocampal CA1 pyramidal cell dendrites via a muscarinic, NMDA-dependent mechanism. J. Neurosci. 13:1010-1021 (1993).
Y. Shishido, M. Furushiro, S. Tanabe, S. Nishiyama, S. Hashimoto, M. Ohno, T. Yamamoto, and S. Watanabe. ZTTA, a post proline cleaving enzyme inhibitor, improves cerebral ischemia-induced deficits in a three-panel runway task in rats. Pharmacol. Biochem. Behav. 55:333-338 (1996).
Y. Shishido, M. Furushiro, S. Tanabe, A. Taniguchi, S. Hashimoto, T. Yokokura, S. Shibata, T. Yamamoto, and S. Watanabe. Effect of ZTTA, a prolyl endopeptidase inhibitor, on memory impairment in a passive avoidance test of rats with basal forebrain lesions. Pharm. Res. 15:1908-1911 (1998).
G. Banker and C. W. Cotman. Characteristics of different amino acids as protein precursors in mouse brain: advantages of certain carboxyl-labeled amino acids. Arch. Biochem. Biophys. 142:565-573 (1971).
J. J. Vornov and J. T. Coyle. Glutamate neurotoxicity and the inhibition of protein synthesis in the hippocampal slice. J. Neurochem. 56:996-1006 (1991).
M. Muhlethaler, J. J. Dreifuss, and B. H. Gahwiler. Vasopressin excites hippocampal neurons. Nature 296:749-751 (1982).
R. E. Brinton and B. S. McEwen. Vasopressin neuromodulation in the hippocampus. J. Neurosci. 9:752-759 (1989).
N. Miura, S. Shibata, and S. Watanabe. Increase in the septal vasopressin content by prolylendopeptidase inhibitors in rats. Neurosci. Lett. 196:128-130 (1995).
G. L. Kovacs, B. Bohus, D. H. G. Versteeg, E. R. De Kloet, and D. De Wied. Effect of oxytocin and vasopressin on memory consolidation: sites of action and catecholaminergic correlates after local microinjection into limbic-midbrain structures. Brain Res. 175:303-314 (1979).
T. Yoshimoto, K. Kado, F. Matsubara, N. Koriyama, H. Kaneto, and D. Tsuru. Specific inhibitor for prolyl endopeptidase and their anti-amnesic effect. J. Pharmacobiodyn. 10:730-735 (1987).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shishido, Y., Tanaka, T., Tanabe, S. et al. ZTTA, a Prolyl Endopeptidase Inhibitor, Potentiates the Arginine-Vasopressin-Induced Incorporation of [14C]Leucine in Rat Amygdaloid and Cortical Slices. Pharm Res 16, 463–465 (1999). https://doi.org/10.1023/A:1011946323792
Issue Date:
DOI: https://doi.org/10.1023/A:1011946323792